The observation that NKTR-214 treatment mediated selective Treg depletion of intratumoral but not of peripheral Tregs suggests that in patients with cancer, NKTR-214-containing regimens could increase tumor control without exacerbating systemic inflammation. Here, NKTR is linked to neoplasm.